{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T12:41:43Z","timestamp":1785415303493,"version":"3.56.0"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2012,10,24]],"date-time":"2012-10-24T00:00:00Z","timestamp":1351036800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["BMC Cardiovasc Disord"],"published-print":{"date-parts":[[2012,12]]},"DOI":"10.1186\/1471-2261-12-93","type":"journal-article","created":{"date-parts":[[2012,10,24]],"date-time":"2012-10-24T16:14:33Z","timestamp":1351095273000},"source":"Crossref","is-referenced-by-count":67,"title":["Comparative effects of non-steroidal anti-inflammatory drugs (NSAIDs) on blood pressure in patients with hypertension"],"prefix":"10.1186","volume":"12","author":[{"given":"Hisham","family":"Aljadhey","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wanzhu","family":"Tu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard A","family":"Hansen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan J","family":"Blalock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D Craig","family":"Brater","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael D","family":"Murray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2012,10,24]]},"reference":[{"issue":"21","key":"493_CR1","doi-asserted-by":"publisher","first-page":"2616","DOI":"10.1001\/jama.291.21.2616","volume":"291","author":"D Yach","year":"2004","unstructured":"Yach D, Hawkes C, Gould CL, Hofman KJ: The global burden of chronic diseases: overcoming impediments to prevention and control. JAMA. 2004, 291 (21): 2616-2622. 10.1001\/jama.291.21.2616.","journal-title":"JAMA"},{"issue":"6","key":"493_CR2","doi-asserted-by":"publisher","first-page":"1206","DOI":"10.1161\/01.HYP.0000107251.49515.c2","volume":"42","author":"AV Chobanian","year":"2003","unstructured":"Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL, et al: Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension. 2003, 42 (6): 1206-1252. 10.1161\/01.HYP.0000107251.49515.c2.","journal-title":"Hypertension"},{"key":"493_CR3","volume-title":"High Blood Pressure Statistics","author":"American Heart Association","year":"2008","unstructured":"American Heart Association: High Blood Pressure Statistics. 2008, Available at: \n                    http:\/\/www.americanheart.org\/presenter.jhtml?identifier=2139\n                    \n                  . Accessed 01\/15\/2008,"},{"issue":"5","key":"493_CR4","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1111\/j.1365-2125.1993.tb04169.x","volume":"35","author":"AG Johnson","year":"1993","unstructured":"Johnson AG, Simons LA, Simons J, Friedlander Y, McCallum J: Non-steroidal anti-inflammatory drugs and hypertension in the elderly: a community-based cross-sectional study. Br J Clin Pharmacol. 1993, 35 (5): 455-459. 10.1111\/j.1365-2125.1993.tb04169.x.","journal-title":"Br J Clin Pharmacol"},{"issue":"5","key":"493_CR5","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1161\/01.HYP.0000035856.77718.DA","volume":"40","author":"J Dedier","year":"2002","unstructured":"Dedier J, Stampfer MJ, Hankinson SE, Willett WC, Speizer FE, Curhan GC: Nonnarcotic analgesic use and the risk of hypertension in US women. Hypertension. 2002, 40 (5): 604-608. 10.1161\/01.HYP.0000035856.77718.DA.","journal-title":"Hypertension"},{"issue":"16","key":"493_CR6","doi-asserted-by":"publisher","first-page":"1903","DOI":"10.1001\/archinte.165.16.1903","volume":"165","author":"T Kurth","year":"2005","unstructured":"Kurth T, Hennekens CH, Sturmer T, Sesso HD, Glynn RJ, Buring JE, et al: Analgesic use and risk of subsequent hypertension in apparently healthy men. Arch Intern Med. 2005, 165 (16): 1903-1909. 10.1001\/archinte.165.16.1903.","journal-title":"Arch Intern Med"},{"issue":"2","key":"493_CR7","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1161\/01.HYP.0000136134.31846.83","volume":"44","author":"DH Solomon","year":"2004","unstructured":"Solomon DH, Schneeweiss S, Levin R, Avorn J: Relationship between COX-2 specific inhibitors and hypertension. Hypertension. 2004, 44 (2): 140-145. 10.1161\/01.HYP.0000136134.31846.83.","journal-title":"Hypertension"},{"issue":"6","key":"493_CR8","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1345\/aph.1H659","volume":"41","author":"J Wang","year":"2007","unstructured":"Wang J, Mullins CD, Mamdani M, Rublee DA, Shaya FT: New diagnosis of hypertension among celecoxib and nonselective NSAID users: a population-based cohort study. Ann Pharmacother. 2007, 41 (6): 937-943. 10.1345\/aph.1H659.","journal-title":"Ann Pharmacother"},{"issue":"2","key":"493_CR9","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1097\/00045391-200103000-00003","volume":"8","author":"A Whelton","year":"2001","unstructured":"Whelton A, Fort JG, Puma JA, Normandin D, Bello AE, Verburg KM: Cyclooxygenase-2--specific inhibitors and cardiorenal function: a randomized, controlled trial of celecoxib and rofecoxib in older hypertensive osteoarthritis patients. Am J Ther. 2001, 8 (2): 85-95. 10.1097\/00045391-200103000-00003.","journal-title":"Am J Ther"},{"issue":"3","key":"493_CR10","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1177\/030006058801600302","volume":"16","author":"JG Davies","year":"1988","unstructured":"Davies JG, Rawlins DC, Busson M: Effect of ibuprofen on blood pressure control by propranolol and bendrofluazide. J Int Med Res. 1988, 16 (3): 173-181.","journal-title":"J Int Med Res"},{"issue":"4","key":"493_CR11","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1038\/clpt.1989.162","volume":"46","author":"JT Wright","year":"1989","unstructured":"Wright JT, McKenney JM, Lehany AM, Bryan DL, Cooper LW, Lambert CM: The effect of high-dose short-term ibuprofen on antihypertensive control with hydrochlorothiazide. Clin Pharmacol Ther. 1989, 46 (4): 440-444. 10.1038\/clpt.1989.162.","journal-title":"Clin Pharmacol Ther"},{"issue":"10","key":"493_CR12","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1002\/j.1552-4604.1993.tb01932.x","volume":"33","author":"D Klassen","year":"1993","unstructured":"Klassen D, Goodfriend TL, Schuna AA, Young DY, Peterson CA: Assessment of blood pressure during treatment with naproxen or ibuprofen in hypertensive patients treated with hydrochlorothiazide. J Clin Pharmacol. 1993, 33 (10): 971-978.","journal-title":"J Clin Pharmacol"},{"issue":"8","key":"493_CR13","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1097\/00004872-199508000-00014","volume":"13","author":"J Polonia","year":"1995","unstructured":"Polonia J, Boaventura I, Gama G, Camoes I, Bernardo F, Andrade P, et al: Influence of non-steroidal anti-inflammatory drugs on renal function and 24h ambulatory blood pressure-reducing effects of enalapril and nifedipine gastrointestinal therapeutic system in hypertensive patients. J Hypertens. 1995, 13 (8): 925-931. 10.1097\/00004872-199508000-00014.","journal-title":"J Hypertens"},{"issue":"10","key":"493_CR14","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1001\/archinte.1995.00430100075009","volume":"155","author":"MC Houston","year":"1995","unstructured":"Houston MC, Weir M, Gray J, Ginsberg D, Szeto C, Kaihlenen PM, et al: The effects of nonsteroidal anti-inflammatory drugs on blood pressures of patients with hypertension controlled by verapamil. Arch Intern Med. 1995, 155 (10): 1049-1054. 10.1001\/archinte.1995.00430100075009.","journal-title":"Arch Intern Med"},{"issue":"2","key":"493_CR15","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/0895-7061(94)00164-7","volume":"8","author":"DK Klassen","year":"1995","unstructured":"Klassen DK, Jane LH, Young DY, Peterson CA: Assessment of blood pressure during naproxen therapy in hypertensive patients treated with nicardipine. Am J Hypertens. 1995, 8 (2): 146-153. 10.1016\/0895-7061(94)00164-7.","journal-title":"Am J Hypertens"},{"issue":"2","key":"493_CR16","doi-asserted-by":"publisher","first-page":"M74","DOI":"10.1093\/gerona\/51A.2.M74","volume":"51","author":"JH Gurwitz","year":"1996","unstructured":"Gurwitz JH, Everitt DE, Monane M, Glynn RJ, Choodnovskiy I, Beaudet MP, et al: The impact of ibuprofen on the efficacy of antihypertensive treatment with hydrochlorothiazide in elderly persons. J Gerontol A Biol Sci Med Sci. 1996, 51 (2): M74-M79.","journal-title":"J Gerontol A Biol Sci Med Sci"},{"issue":"2","key":"493_CR17","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/S0895-7061(98)00228-3","volume":"12","author":"ME Olsen","year":"1999","unstructured":"Olsen ME, Thomsen T, Hassager C, Ibsen H, Dige-Petersen H: Hemodynamic and renal effects of indomethacin in losartan-treated hypertensive individuals. Am J Hypertens. 1999, 12 (2): 209-216. 10.1016\/S0895-7061(98)00228-3.","journal-title":"Am J Hypertens"},{"issue":"11","key":"493_CR18","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.1016\/S0895-7061(00)01204-8","volume":"13","author":"TO Morgan","year":"2000","unstructured":"Morgan TO, Anderson A, Bertram D: Effect of indomethacin on blood pressure in elderly people with essential hypertension well controlled on amlodipine or enalapril. Am J Hypertens. 2000, 13 (11): 1161-1167. 10.1016\/S0895-7061(00)01204-8.","journal-title":"Am J Hypertens"},{"issue":"5","key":"493_CR19","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1097\/00004872-200205000-00037","volume":"20","author":"R Fogari","year":"2002","unstructured":"Fogari R, Zoppi A, Carretta R, Veglio F, Salvetti A: Effect of indomethacin on the antihypertensive efficacy of valsartan and lisinopril: a multicentre study. J Hypertens. 2002, 20 (5): 1007-1014. 10.1097\/00004872-200205000-00037.","journal-title":"J Hypertens"},{"issue":"9","key":"493_CR20","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1016\/S0002-9149(02)02661-9","volume":"90","author":"A Whelton","year":"2002","unstructured":"Whelton A, White WB, Bello AE, Puma JA, Fort JG: Effects of celecoxib and rofecoxib on blood pressure and edema in patients > or =65 years of age with systemic hypertension and osteoarthritis. Am J Cardiol. 2002, 90 (9): 959-963. 10.1016\/S0002-9149(02)02661-9.","journal-title":"Am J Cardiol"},{"issue":"4","key":"493_CR21","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1161\/01.HYP.0000014323.99765.16","volume":"39","author":"WB White","year":"2002","unstructured":"White WB, Kent J, Taylor A, Verburg KM, Lefkowith JB, Whelton A: Effects of celecoxib on ambulatory blood pressure in hypertensive patients on ACE inhibitors. Hypertension. 2002, 39 (4): 929-934. 10.1161\/01.HYP.0000014323.99765.16.","journal-title":"Hypertension"},{"issue":"2","key":"493_CR22","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/S0895-7061(02)03203-X","volume":"16","author":"R Palmer","year":"2003","unstructured":"Palmer R, Weiss R, Zusman RM, Haig A, Flavin S, MacDonald B: Effects of nabumetone, celecoxib, and ibuprofen on blood pressure control in hypertensive patients on angiotensin converting enzyme inhibitors. Am J Hypertens. 2003, 16 (2): 135-139. 10.1016\/S0895-7061(02)03203-X.","journal-title":"Am J Hypertens"},{"issue":"3","key":"493_CR23","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1161\/01.HYP.0000115921.55353.e0","volume":"43","author":"M Izhar","year":"2004","unstructured":"Izhar M, Alausa T, Folker A, Hung E, Bakris GL: Effects of COX inhibition on blood pressure and kidney function in ACE inhibitor-treated blacks and hispanics. Hypertension. 2004, 43 (3): 573-577. 10.1161\/01.HYP.0000115921.55353.e0.","journal-title":"Hypertension"},{"issue":"2","key":"493_CR24","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1001\/archinte.165.2.161","volume":"165","author":"JR Sowers","year":"2005","unstructured":"Sowers JR, White WB, Pitt B, Whelton A, Simon LS, Winer N, et al: The Effects of cyclooxygenase-2 inhibitors and nonsteroidal anti-inflammatory therapy on 24-hour blood pressure in patients with hypertension, osteoarthritis, and type 2 diabetes mellitus. Arch Intern Med. 2005, 165 (2): 161-168.","journal-title":"Arch Intern Med"},{"issue":"4","key":"493_CR25","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1197\/jamia.M1252","volume":"10","author":"MD Murray","year":"2003","unstructured":"Murray MD, Smith FE, Fox J, Teal EY, Kesterson JG, Stiffler TA, et al: Structure, functions, and activities of a research support informatics section. J Am Med Inform Assoc. 2003, 10 (4): 389-398. 10.1197\/jamia.M1252.","journal-title":"J Am Med Inform Assoc"},{"issue":"9","key":"493_CR26","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1093\/aje\/kwg231","volume":"158","author":"WA Ray","year":"2003","unstructured":"Ray WA: Evaluating medication effects outside of clinical trials: new-user designs. Am J Epidemiol. 2003, 158 (9): 915-920. 10.1093\/aje\/kwg231.","journal-title":"Am J Epidemiol"},{"issue":"9","key":"493_CR27","doi-asserted-by":"publisher","first-page":"1905","DOI":"10.1002\/1529-0131(200009)43:9<1905::AID-ANR1>3.0.CO;2-P","volume":"43","author":"American College of Rheumatology Subcommittee on Osteoarthritis Guidelines","year":"2000","unstructured":"American College of Rheumatology Subcommittee on Osteoarthritis Guidelines: Recommendations for the medical management of osteoarthritis of the hip and knee: 2000 update. Arthritis Rheum. 2000, 43 (9): 1905-1915.","journal-title":"Arthritis Rheum"},{"issue":"19","key":"493_CR28","doi-asserted-by":"publisher","first-page":"2265","DOI":"10.1002\/(SICI)1097-0258(19981015)17:19<2265::AID-SIM918>3.0.CO;2-B","volume":"17","author":"RB D\u2019Agostino Jr","year":"1998","unstructured":"D\u2019Agostino RB: Propensity score methods for bias reduction in the comparison of a treatment to a non-randomized control group. Stat Med. 1998, 17 (19): 2265-2281. 10.1002\/(SICI)1097-0258(19981015)17:19<2265::AID-SIM918>3.0.CO;2-B.","journal-title":"Stat Med"},{"issue":"6","key":"493_CR29","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1111\/j.1524-4733.2006.00130.x","volume":"9","author":"O Baser","year":"2006","unstructured":"Baser O: Too much ado about propensity score models? Comparing methods of propensity score matching. Value Health. 2006, 9 (6): 377-385. 10.1111\/j.1524-4733.2006.00130.x.","journal-title":"Value Health"},{"issue":"19","key":"493_CR30","doi-asserted-by":"publisher","first-page":"1690","DOI":"10.1001\/jama.280.19.1690","volume":"280","author":"J Zhang","year":"1998","unstructured":"Zhang J, Yu KF: What\u2019s the Relative Risk. JAMA. 1998, 280 (19): 1690-1691. 10.1001\/jama.280.19.1690.","journal-title":"JAMA"},{"key":"493_CR31","volume-title":"Facts & Comparisons 4.0","author":"Drug Facts and Comparisons","year":"2001","unstructured":"Drug Facts and Comparisons: Facts & Comparisons 4.0. 2001, St. Louis, Mo: Wolters Kluwer Health"},{"issue":"3","key":"493_CR32","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1370\/afm.76","volume":"2","author":"WM Tierney","year":"2004","unstructured":"Tierney WM, Brunt M, Kesterson J, Zhou XH, L\u2019Italien G, Lapuerta P: Quantifying risk of adverse clinical events with one set of vital signs among primary care patients with hypertension. Ann Fam Med. 2004, 2 (3): 209-217. 10.1370\/afm.76.","journal-title":"Ann Fam Med"},{"issue":"11","key":"493_CR33","doi-asserted-by":"publisher","first-page":"1416","DOI":"10.1592\/phco.23.14.1416.31935","volume":"23","author":"PJ Nietert","year":"2003","unstructured":"Nietert PJ, Ornstein SM, Dickerson LM, Rothenberg RJ: Comparison of changes in blood pressure measurements and antihypertensive therapy in older, hypertensive, ambulatory care patients prescribed celecoxib or rofecoxib. Pharmacotherapy. 2003, 23 (11): 1416-1423. 10.1592\/phco.23.14.1416.31935.","journal-title":"Pharmacotherapy"},{"key":"493_CR34","first-page":"203s","volume":"4","author":"JA Lopez-Ovejero","year":"1978","unstructured":"Lopez-Ovejero JA, Weber MA, Drayer JI, Sealey JE, Laragh JH: Effects of indomethacin alone and during diuretic or beta-adrenoreceptor-blockade therapy on blood pressure and the renin system in essential hypertension. Clin Sci Mol Med Suppl. 1978, 4: 203s-205s.","journal-title":"Clin Sci Mol Med Suppl"},{"issue":"4","key":"493_CR35","doi-asserted-by":"publisher","first-page":"289","DOI":"10.7326\/0003-4819-121-4-199408150-00011","volume":"121","author":"AG Johnson","year":"1994","unstructured":"Johnson AG, Nguyen TV, Day RO: Do nonsteroidal anti-inflammatory drugs affect blood pressure? A meta-analysis. Ann Intern Med. 1994, 121 (4): 289-300.","journal-title":"Ann Intern Med"},{"issue":"4","key":"493_CR36","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1111\/j.1445-5994.1986.tb02031.x","volume":"16","author":"A Davis","year":"1986","unstructured":"Davis A, Day RO, Begg EJ: Interactions between non-steroidal anti-inflammatory drugs and antihypertensives and diuretics. Aust N Z J Med. 1986, 16 (4): 537-546. 10.1111\/j.1445-5994.1986.tb02031.x.","journal-title":"Aust N Z J Med"},{"issue":"1","key":"493_CR37","first-page":"85","volume":"1","author":"M Epstein","year":"1985","unstructured":"Epstein M, Oster JR: Beta blockers and renal function: a reappraisal. J Clin Hypertens. 1985, 1 (1): 85-99.","journal-title":"J Clin Hypertens"},{"issue":"4","key":"493_CR38","first-page":"849","volume":"51","author":"LL MacFarlane","year":"1995","unstructured":"MacFarlane LL, Orak DJ, Simpson WM: NSAIDs, antihypertensive agents and loss of blood pressure control. Am Fam Physician. 1995, 51 (4): 849-856.","journal-title":"Am Fam Physician"},{"issue":"Suppl 1","key":"493_CR39","doi-asserted-by":"publisher","first-page":"S4","DOI":"10.2337\/dc07-S004","volume":"30","author":"American Diabetes Association","year":"2007","unstructured":"American Diabetes Association: Standards of medical care in diabetes--2007. Diabetes Care. 2007, 30 (Suppl 1): S4-S41.","journal-title":"Diabetes Care"},{"issue":"1","key":"493_CR40","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1161\/01.HYP.0000149684.01903.b8","volume":"45","author":"SA Grover","year":"2005","unstructured":"Grover SA, Coupal L, Zowall H: Treating osteoarthritis with cyclooxygenase-2-specific inhibitors: what are the benefits of avoiding blood pressure destabilization?. Hypertension. 2005, 45 (1): 92-97.","journal-title":"Hypertension"},{"issue":"9349","key":"493_CR41","doi-asserted-by":"publisher","first-page":"1903","DOI":"10.1016\/S0140-6736(02)11911-8","volume":"360","author":"S Lewington","year":"2002","unstructured":"Lewington S, Clarke R, Qizilbash N, Peto R, Collins R: Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet. 2002, 360 (9349): 1903-1913.","journal-title":"Lancet"},{"issue":"18","key":"493_CR42","doi-asserted-by":"publisher","first-page":"1789","DOI":"10.1161\/CIRCULATIONAHA.110.956490","volume":"122","author":"I Sudano","year":"2010","unstructured":"Sudano I, Flammer AJ, P\u00e9riat D, Enseleit F, Hermann M, Wolfrum M, et al: Acetaminophen increases blood pressure in patients with coronary artery disease. Circulation. 2010, 122 (18): 1789-1796. 10.1161\/CIRCULATIONAHA.110.956490. Nov 2","journal-title":"Circulation"},{"issue":"9","key":"493_CR43","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1002\/pds.1454","volume":"16","author":"MU Yood","year":"2007","unstructured":"Yood MU, Campbell UB, Rothman KJ, Jick SS, Lang J, Wells KE, et al: Using prescription claims data for drugs available over-the-counter (OTC). Pharmacoepidemiol Drug Saf. 2007, 16 (9): 961-968. 10.1002\/pds.1454.","journal-title":"Pharmacoepidemiol Drug Saf"}],"container-title":["BMC Cardiovascular Disorders"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-2261-12-93\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2261-12-93.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2261-12-93","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2261-12-93.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,1,22]],"date-time":"2019-01-22T20:29:07Z","timestamp":1548188947000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccardiovascdisord.biomedcentral.com\/articles\/10.1186\/1471-2261-12-93"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,10,24]]},"references-count":43,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,12]]}},"alternative-id":["493"],"URL":"https:\/\/doi.org\/10.1186\/1471-2261-12-93","relation":{},"ISSN":["1471-2261"],"issn-type":[{"value":"1471-2261","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,10,24]]},"article-number":"93"}}